| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/13/2003 | WO2003012430A1 Use of dye to distinguish salt and protein crystals under microcrystallization conditions |
| 02/13/2003 | WO2003011909A1 Binding agents with differential activity |
| 02/13/2003 | WO2003011907A2 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | WO2003011894A1 The production of soluble keratin derivatives |
| 02/13/2003 | WO2002053723B1 Degradation and detection of tse infectivity |
| 02/13/2003 | WO2002020752A3 Cloned cells, embryos, and avians and methods, of producing them |
| 02/13/2003 | WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 02/13/2003 | WO2001070772A3 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid |
| 02/13/2003 | US20030033088 Method of generating chemical compounds having desired properties |
| 02/13/2003 | US20030032842 Novel arylpropyl aldehyde derivatives, processes for producing the same, and methods of using the same |
| 02/13/2003 | US20030032780 Process for inactivating pionts in lipoproteins |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032594 Intracellular delivery of biological effectors |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032146 Enzyme/tag binding and detection system |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032083 Biosynthesis of preferential peptide; obtain amino acid sequence, ligate protection group, deprotect peptide, recover peptide |
| 02/13/2003 | US20030032065 Ensemble-based strategy for the design of protein pharmaceuticals |
| 02/13/2003 | US20030032011 Method and apparatus for generating polycyclic fragments |
| 02/13/2003 | US20030029714 Manipulation of solid, semi-solid or liquid materials |
| 02/13/2003 | CA2455154A1 Receptor, the use thereof, and mouse antibodies |
| 02/12/2003 | EP1283270A1 Supported membrane, preparation and use |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283212A1 Methods for identifying compounds that bind to a target |
| 02/12/2003 | EP1282816A2 Improved assay techniques using nematode worms |
| 02/12/2003 | EP1282637A2 Purification of protein inclusion bodies by crossflow microfiltration |
| 02/12/2003 | EP0717749B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 02/12/2003 | CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/12/2003 | CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1396175A Process for extracting both active embryonic peptide and natural corn oil from embryo bud of corn |
| 02/12/2003 | CN1101402C Sericin polypeptide extracted from frison, husks and waste silk and method |
| 02/11/2003 | US6519611 Method and apparatus for computer automated detection of protein and nucleic acid targets of a chemical compound |
| 02/11/2003 | US6518436 Process for preparing pharmacologically acceptable salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid |
| 02/11/2003 | US6518241 Shock heat treatment of polypeptides |
| 02/11/2003 | US6518067 Automated chemical synthesis apparatus |
| 02/11/2003 | US6518040 In vitro production of proteins by translation of mRNA immobilized on a solid surface |
| 02/11/2003 | US6518022 Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic device |
| 02/11/2003 | US6518018 RNA-antibody fusions and their selection |
| 02/11/2003 | US6517829 Cells having expressed and immobilised at their outer surface active heavy chain antibodies from an animal in the family Camelidae |
| 02/11/2003 | CA2109516C Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 02/11/2003 | CA2036657C Temporary minimal protection synthesis of lh-rh analogs |
| 02/07/2003 | CA2397182A1 New supported membrane, its preparation and uses |
| 02/06/2003 | WO2003010512A2 High-speed, solid-liquid separation |
| 02/06/2003 | WO2003010204A1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 02/06/2003 | WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | WO2003010186A2 Method for making acylated polypeptides |
| 02/06/2003 | WO2003010185A2 Method for making acylated polypeptides |
| 02/06/2003 | WO2003010183A2 Process for preparing variant polynucleotides |
| 02/06/2003 | WO2003010176A2 Protein-nucleic acid complexes |
| 02/06/2003 | WO2002097134A3 Modified peptide nucleic acid |
| 02/06/2003 | WO2002063005A3 Lipid-associated molecules |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2002019963A3 Synthetic erythropoiesis stimulating proteins |
| 02/06/2003 | WO2001070765A9 Receptor-binding compounds and methods for identifying them |
| 02/06/2003 | US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027982 Generation of preferential peptide on solid support; generate solid support, join to substrate, expose to reaction mixture, recover peptide |
| 02/06/2003 | US20030027819 Administering to an animal in need for protease inhibition an effective amount of substituted heterobicyclic compound containing amino acid side chains |
| 02/06/2003 | US20030027759 Method of using PON-1 to decrease atheroma formation |
| 02/06/2003 | US20030027348 Monitoring protein propagation in solution; provide a microarray, accurately dispense proein solution, monitor protein propagation or precipitation in solution |
| 02/06/2003 | US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027214 Detection of interacting substrate ligands; obtain ligands, incubate with solid support, detect signal from formation of ligand/substrate complex, determine position of signal |
| 02/06/2003 | US20030027212 Antibody for use in tissue classification |
| 02/06/2003 | US20030027142 Novel genome analyzing method |
| 02/06/2003 | US20030026745 Reaction device for organic synthesis |
| 02/06/2003 | US20030026740 Microfluidic devices |
| 02/06/2003 | CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | CA2452735A1 Method for making acylated polypeptides |
| 02/05/2003 | EP1281716A2 Purification process based on enzyme/tagged-peptide binding |
| 02/05/2003 | EP1281405A2 Short-chained peptide-dye conjugates as contrast agents for optical diagnosis |
| 02/05/2003 | EP1280919A2 Lipolytic enzyme variants |
| 02/05/2003 | EP1280819A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 02/05/2003 | EP1280817A2 Production and use of protein variants having modified immunogenecity |
| 02/05/2003 | EP1280566A2 Growth factor modified protein matrices for tissue engineering |
| 02/05/2003 | EP1280545A2 Cross-linked collagen matrices and methods for their preparation |
| 02/05/2003 | EP1117999B1 Characterising polypeptides through cleavage and mass spectrometry |
| 02/05/2003 | CN1395551A Novel arylpropionaldehyde derivatives and production and use of the same |
| 02/05/2003 | CN1394875A Method for extracting fimbrin |
| 02/05/2003 | CN1100877C Pencillin V. amidohydrrolase gene from fusarium oxysporum |
| 02/05/2003 | CN1100873C Process and equipment for purifying glucose oxidase |
| 02/05/2003 | CN1100785C 1,3,4,5-tetrahydrobenzo [c] azepin-3-one disulfide derivative and method |
| 02/04/2003 | US6515110 Multivalent antigen-binding proteins |
| 02/04/2003 | US6515039 Method for the parallel and combinatory synthesis of compounds bound to a continuous polymeric solid phase supporting material |
| 02/04/2003 | US6514753 Expression vectors for producing modified proteins |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 01/30/2003 | WO2003008958A1 Free flow electrophoresis element and free flow electrophoresis method |
| 01/30/2003 | WO2003008378A1 Dolastatin 10 derivatives |
| 01/30/2003 | WO2003008088A2 Method and assembly for attaching substances that have been immobilised in transport agents and monomer particles |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007689A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | WO2002058533A3 Process for determining target function and identifying drug leads |
| 01/30/2003 | WO2002055538A3 Continuous separation method |